DK1448220T3 - Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf - Google Patents
Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse derafInfo
- Publication number
- DK1448220T3 DK1448220T3 DK02792816T DK02792816T DK1448220T3 DK 1448220 T3 DK1448220 T3 DK 1448220T3 DK 02792816 T DK02792816 T DK 02792816T DK 02792816 T DK02792816 T DK 02792816T DK 1448220 T3 DK1448220 T3 DK 1448220T3
- Authority
- DK
- Denmark
- Prior art keywords
- antiflogistically
- active substance
- agent containing
- pharmaceutical agent
- lactalbumin hydrolyzate
- Prior art date
Links
- 102000004407 Lactalbumin Human genes 0.000 title abstract 2
- 108090000942 Lactalbumin Proteins 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10158039A DE10158039A1 (de) | 2001-11-27 | 2001-11-27 | Antiphlogistisches Mittel und dessen Verwendung |
| PCT/EP2002/013385 WO2003045416A2 (de) | 2001-11-27 | 2002-11-27 | Antiphlogistisches mittel und dessen verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1448220T3 true DK1448220T3 (da) | 2008-11-03 |
Family
ID=7707054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02792816T DK1448220T3 (da) | 2001-11-27 | 2002-11-27 | Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050054556A1 (da) |
| EP (1) | EP1448220B1 (da) |
| AT (1) | ATE400286T1 (da) |
| AU (1) | AU2002358551A1 (da) |
| CY (1) | CY1108402T1 (da) |
| DE (2) | DE10158039A1 (da) |
| DK (1) | DK1448220T3 (da) |
| ES (1) | ES2309221T3 (da) |
| PT (1) | PT1448220E (da) |
| WO (1) | WO2003045416A2 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070190130A1 (en) * | 2006-02-16 | 2007-08-16 | Mark William A | Protein hydrolysate excipients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1029660A (en) * | 1973-06-01 | 1978-04-18 | Kyowa Hakko Kogyo Co. | Prevention of gastric lesions |
| DE3661339D1 (en) * | 1985-01-18 | 1989-01-12 | Gauri Kailash Kumar | Protein hydrolysates, production process and drugs containing th em |
| EP0326618A1 (en) * | 1987-03-04 | 1989-08-09 | Nippon Hypox Laboratories Incorporated | Medicinal composition containing albumin as carrier and process for its preparation |
| CA1324083C (en) * | 1987-03-09 | 1993-11-09 | Tetsu Miyoshi | Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
| AU3860797A (en) * | 1997-07-16 | 1999-02-10 | Antrin Research Limited | Pharmaceutical formulations for oral administration |
-
2001
- 2001-11-27 DE DE10158039A patent/DE10158039A1/de not_active Ceased
-
2002
- 2002-11-27 AT AT02792816T patent/ATE400286T1/de active
- 2002-11-27 US US10/496,692 patent/US20050054556A1/en not_active Abandoned
- 2002-11-27 AU AU2002358551A patent/AU2002358551A1/en not_active Abandoned
- 2002-11-27 DE DE50212485T patent/DE50212485D1/de not_active Expired - Lifetime
- 2002-11-27 DK DK02792816T patent/DK1448220T3/da active
- 2002-11-27 EP EP02792816A patent/EP1448220B1/de not_active Expired - Lifetime
- 2002-11-27 WO PCT/EP2002/013385 patent/WO2003045416A2/de not_active Ceased
- 2002-11-27 ES ES02792816T patent/ES2309221T3/es not_active Expired - Lifetime
- 2002-11-27 PT PT02792816T patent/PT1448220E/pt unknown
-
2008
- 2008-10-08 CY CY20081101115T patent/CY1108402T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003045416A3 (de) | 2003-12-24 |
| US20050054556A1 (en) | 2005-03-10 |
| AU2002358551A8 (en) | 2003-06-10 |
| AU2002358551A1 (en) | 2003-06-10 |
| ATE400286T1 (de) | 2008-07-15 |
| ES2309221T3 (es) | 2008-12-16 |
| EP1448220A2 (de) | 2004-08-25 |
| DE10158039A1 (de) | 2003-07-03 |
| EP1448220B1 (de) | 2008-07-09 |
| PT1448220E (pt) | 2008-10-15 |
| WO2003045416A2 (de) | 2003-06-05 |
| CY1108402T1 (el) | 2014-02-12 |
| DE50212485D1 (de) | 2008-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| EE03473B1 (et) | Prootonpumba inhibiitorit sisaldav farmatseutiline kompositsioon | |
| HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
| MXPA02006679A (es) | Composicion farmaceutica. | |
| NO20100061L (no) | Forhindring og behandling av amyloidogen sykdom | |
| DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
| HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| EE03969B1 (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
| DK0862424T3 (da) | Farmaceutiske præparater omfattende flurbiprofen | |
| ES2168457T3 (es) | Composiciones farmaceuticas que comprenden una superoxido dismutasa. | |
| ATE273693T1 (de) | Proteinhaltige arzneimittel | |
| HUP0002247A2 (hu) | Proteáz inhibitorok | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| ATE400552T1 (de) | 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen | |
| NO995838L (no) | Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme | |
| CY1108402T1 (el) | Φαρμακευτικο μεσο που περιεχει μια αντιφλεγμονωδη δραστικη ουσια και υδρολυμα λακταλβουμινης και χρηση αυτου | |
| DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
| DK1448219T3 (da) | Antiglaukomatöst middel og anvendelse deraf | |
| ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
| SE9904132D0 (sv) | Pharmaceutical composition for treatment of diarrhea | |
| TR200202110T2 (tr) | "5-[{6-(2-Flüore benzil) oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri" | |
| DE60122764D1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
| UA37445A (uk) | Протизапальний засіб | |
| UA41781A (uk) | Спосіб лікування хворих на остеоартроз |